Skip to main content
. 2022 Feb 5;26(8):2623–2631. doi: 10.1007/s10461-022-03592-x

Table 3.

Factors associated with self-reported oral PrEP continuation at the final study visit (median of 3 months) among 131 women

Characteristic Total n (%) Oral PrEP continuation at the final trial visit (median = 91 days) n (%) Odds ratio (OR) (95% confidence interval [CI]) p value Adjusted OR (95% CI)a p value
Yes No
Age > 24 years 50 (38) 40 (40) 10 (31) 1.49 (0.64, 3.48) 0.36
Age ≤ 24 years (ref) 81 (62) 59 (60) 22 (69)
Education (secondary level or higher) 82 (63) 62 (63) 20 (63) 1.01 (0.44, 2.29) 0.99
Education (secondary level—incomplete) (ref) 49 (37) 37 (37) 12 (38)
Relationship status 0.35
 Lives with partner 9 (7) 8 (8) 1 (3) 2.76 (0.33, 22.92)
 Does not live with partner (ref) 121 (93) 90 (92) 31 (97)
Earns an income 22 (17) 18 (18) 4 (13) 1.56 (0.48, 4.99) 0.46
Does not earn an income (ref) 109 (83) 81 (82) 28 (88)
STI diagnosis at enrolment
 Chlamydia trachomatis detected 32 (24) 22 (22) 10 (31) 0.63 (0.26, 1.52) 0.30
 Chlamydia trachomatis not detected (ref) 99 (76) 77 (78) 22 (69)
 Neisseria gonorrhoea detected 3 (2) 3 (3) 0 (0)
 Neisseria gonorrhoea not detected (ref) 128 (98) 96 (97) 32 (100)
Unknown partner HIV status 20 (15) 14 (14) 6 (19) 0.71 (0.25, 2.04) 0.53
Partner is HIV-negative (ref) 111 (85) 85 (86) 26 (81)
More than 1 sex partner 9 (7) 4 (4) 5 (16) 0.23 (0.06, 0.91) 0.04 0.24 (0.06, 0.97) 0.05
Has 0/1 sex partner (ref) 122 (93) 95 (96) 27 (84)
> 12 sex acts in the last 3 months 17 (14) 13 (14) 4 (14) 1.02 (0.30, 3.40) 0.97
≤ 12 sex acts in last 3 months (ref) 105 (86) 80 (86) 25 (86)
Any unprotected sex in last 3 months 88 (72) 67 (72) 21 (72) 0.98 (0.39, 2.49) 0.97
No unprotected sex (always used condoms) (ref) 34 (28) 26 (28) 8 (28)
HIV risk perception 0.21 (0.08, 0.55)  < 0.01
 I will probably/definitely get infected with HIV 30 (25) 17 (18) 13 (48) 0.24 (0.10, 0.60)  < 0.01
 I will probably/definitely not get infected with HIV (ref) 90 (75) 76 (82) 14 (52)
 Disclosed oral PrEP use 118 (90) 93 (94) 25 (78) 4.34 (1.34, 14.07) 0.01 4.98 (1.45, 17.13) 0.01
 Did not disclose oral PrEP use (ref) 13 (10) 6 (6) 7 (22)

Bold values indicate p ≤ 0.05

aFactors associated with oral PrEP continuation at p < 0.05 are included in the multivariate analysis in which we adjust for a priori confounders (age (continuous) and relationship status)